Alla Arzumanyan

Alla Arzumanyan's Title

Alla Arzumanyan holds the prestigious title of Chief Development Officer (CDO) and is a co-founder of her current venture. In this role, she leverages her extensive expertise and leadership skills to drive the strategic development and innovation of the company's biotechnological solutions. Her position as a CDO involves overseeing the development processes, ensuring the company’s projects are aligned with the latest scientific advancements and market needs.

Alla Arzumanyan's Education and Expertise

Alla Arzumanyan earned her PhD in Biotechnology from Yerevan University, Armenia, which laid the foundation for her distinguished career in the field. Her expertise spans critical areas such as stem cell cancers, Hepatitis B virus (HBV), and the gastrointestinal (GI) microbiome. This specialized knowledge has been instrumental in advancing research and development efforts in these complex domains, positioning her as a leading expert in biotechnological innovations.

Alla Arzumanyan's Background

With a robust academic background, Alla Arzumanyan has served as an Assistant Professor at both Temple University and Jefferson University. Her academic roles involved teaching, conducting groundbreaking research, and mentoring the next generation of biotechnologists. This experience not only honed her research skills but also expanded her professional network, fostering collaborations that have been vital to her career advancements.

Alla Arzumanyan's Achievements

Alla Arzumanyan's career is marked by numerous achievements over her 25 years in the biotechnology field. She has contributed significantly to the research on stem cell cancers, HBV, and the GI microbiome. Her work with notable companies such as HEC (Sunshine Lake Pharma Co.), Theravectys, and ThirdLaw underscores her ability to translate complex scientific research into practical applications. These accomplishments highlight her role as a pivotal figure in advancing biotechnological research and development.